Oldest pages

From NeuroRehab.wiki

Showing below up to 50 results in range #601 to #650.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. PARKINSONS (MILD TO MODERATE) Tx-MAO B INHIBITOR‏‎ (03:41, 21 February 2023)
  2. NEUROPATHY-PATTERNS OF INVOLVEMENT‏‎ (03:41, 21 February 2023)
  3. STROKE-ICH MANAGEMENT, SUPRATENTORIAL‏‎ (03:41, 21 February 2023)
  4. MND-MUSCLE CONTRACTURES‏‎ (03:41, 21 February 2023)
  5. STROKE-ECR (ENDOVASCULAR CLOT RETRIEVAL)‏‎ (03:41, 21 February 2023)
  6. CLINICAL-ARGYLL ROBERTSON PUPIL‏‎ (03:41, 21 February 2023)
  7. MYASTHENIA GRAVIS-MANAGEMENT‏‎ (03:41, 21 February 2023)
  8. CLINICAL-NYSTAGMUS‏‎ (03:41, 21 February 2023)
  9. NCS-EMG (ABNORMAL RESTING MUSCLE ACTIVITY)‏‎ (03:41, 21 February 2023)
  10. CNS INFECTIONS-CJD‏‎ (03:41, 21 February 2023)
  11. PARKINSONS & PARKINSONISM-LSVT BIG‏‎ (03:41, 21 February 2023)
  12. STROKE-ATTENTION (NON PHARMACOLOGIC) MGM‏‎ (03:41, 21 February 2023)
  13. MND-RESPIRATORY SYMPTOMS‏‎ (03:41, 21 February 2023)
  14. STROKE-PROGNOSTIC FACTORS‏‎ (03:41, 21 February 2023)
  15. STROKE-ICH (INTRACEREBRAL HAEMORRHAGE)‏‎ (03:41, 21 February 2023)
  16. CLINICAL-CAUSES OF ANOSMIA‏‎ (03:41, 21 February 2023)
  17. STROKE-tPA COMPLICATIONS‏‎ (03:41, 21 February 2023)
  18. SEIZURES-MANAGEMENT OF FOCAL SEIZURES‏‎ (03:41, 21 February 2023)
  19. NCS-MOTOR TESTING PARAMETERS‏‎ (03:41, 21 February 2023)
  20. LUMBAR PUNCTURE-INVESTIGATIONS‏‎ (03:41, 21 February 2023)
  21. PARKINSONS & PARKINSONISM-PHARMACOLOGIC MGM‏‎ (03:41, 21 February 2023)
  22. DIZZINESS-CAUSES OF VERTIGO‏‎ (03:41, 21 February 2023)
  23. NEUROPATHY-CIDP VARIANTS‏‎ (03:41, 21 February 2023)
  24. COMA-LOCKED IN SYNDROME‏‎ (03:41, 21 February 2023)
  25. MND-AMYOTROPHIC LATERAL SCLEROSIS (ALS)‏‎ (03:41, 21 February 2023)
  26. GUILLAIN BARRE SYNDROME (GBS)-PATHOLOGY‏‎ (03:41, 21 February 2023)
  27. STROKE-COGNITIVE RECOVERY‏‎ (03:41, 21 February 2023)
  28. STROKE-RISK FACTORS, NON MODIFIABLE‏‎ (03:41, 21 February 2023)
  29. MULTIPLE SCLEROSIS-DEPRESSION‏‎ (03:41, 21 February 2023)
  30. DEMENTIA-ALZHEIMER'S Dz RISK FACTORS‏‎ (03:41, 21 February 2023)
  31. DERMATOMES-C2 TO C4‏‎ (03:41, 21 February 2023)
  32. NCS-CIP & CIM INVESTIGATIONS‏‎ (03:41, 21 February 2023)
  33. PARKINSONS (SEVERE) Tx-L DOPA‏‎ (03:41, 21 February 2023)
  34. NEUROPATHY-POLYNEUROPATHY‏‎ (03:41, 21 February 2023)
  35. STROKE-INTRA ARTERIAL THROMBOLYTIC THERAPY‏‎ (03:41, 21 February 2023)
  36. MND-PAIN IN ALS‏‎ (03:41, 21 February 2023)
  37. HEADACHE-CLUSTER HEADACHE‏‎ (03:41, 21 February 2023)
  38. DEMENTIA-DIAGNOSIS‏‎ (03:41, 21 February 2023)
  39. MYASTHENIA GRAVIS-MYAESTHENIC CRISIS‏‎ (03:41, 21 February 2023)
  40. NCS-EMG (MOTOR UNIT ACTION POTENTIAL, MUAP)‏‎ (03:41, 21 February 2023)
  41. GUILLAIN BARRE SYNDROME (GBS)-POOR PROGNOSIS‏‎ (10:34, 21 February 2023)
  42. MIGRAINE-PROPHYLACTIC MANAGEMENT‏‎ (10:34, 21 February 2023)
  43. DEMENTIA TYPE-ALZHEIMER'S DEMENTIA‏‎ (10:34, 21 February 2023)
  44. CNS INFECTIONS-CRYPTOCOCCAL MENINGITIS‏‎ (10:34, 21 February 2023)
  45. STROKE-RISK FACTORS, MODIFIABLE‏‎ (11:31, 21 February 2023)
  46. ANTERIOR TIBIAL ARTERY & VEINS‏‎ (11:30, 10 March 2023)
  47. DIURETICS-GUIDE‏‎ (20:03, 13 March 2023)
  48. RENAL INX-MICROALBUMINURIA‏‎ (20:03, 13 March 2023)
  49. GLOMERULONEPHRITIS-IgA NEPHROPATHY‏‎ (20:03, 13 March 2023)
  50. RENAL TUBULAR ACIDOSIS (RTA)-TYPE 4‏‎ (20:03, 13 March 2023)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.neurorehab.wiki/wiki/Special:AncientPages"